Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function
Clinical trial NCT04471337 · COMPLETED
Trial details
- NCT number
- NCT04471337
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2021-02-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.